Combining Fluoxetine and rTMS in Poststroke Motor Recovery: A Placebo-Controlled Double-Blind Randomized Phase 2 Clinical Trial

被引:21
|
作者
Pinto, Camila Bonin [1 ,2 ,3 ]
Morales-Quezada, Leon [1 ,3 ]
de Toledo Piza, Polyana Vulcano [1 ,3 ,6 ]
Zeng, Dian [1 ,3 ]
Saleh Velez, Faddi Ghassan [1 ,3 ,4 ]
Ferreira, Isadora Santos [1 ,3 ]
Lucena, Pedro Henrique [1 ,3 ]
Duarte, Dante [1 ,3 ]
Lopes, Fernanda [1 ,3 ]
El-Hagrassy, Mirret M. [1 ,3 ]
Rizzo, Luiz Vicente [3 ]
Camargo, Erica C. [1 ,5 ]
Lin, David J. [1 ,5 ]
Mazwi, Nicole [1 ,3 ,5 ]
Wang, Qing Mei [1 ,5 ,6 ,7 ]
Black-Schaffer, Randie [1 ,3 ,5 ]
Fregni, Felipe [1 ,3 ,5 ]
机构
[1] Harvard Med Sch, Boston, MA 02115 USA
[2] Univ Sao Paulo, Sao Paulo, Brazil
[3] Harvard Med Sch, Spaulding Rehabil Hosp, Boston, MA 02115 USA
[4] Univ Chicago, Med Ctr, Chicago, IL 60637 USA
[5] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA
[6] Albert Einstein Hosp, Sao Paulo, Brazil
[7] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA
关键词
stroke; transcranial magnetic stimulation; fluoxetine; motor recovery; recovery of function; cortical excitability; TRANSCRANIAL MAGNETIC STIMULATION; ENDOTHELIAL GROWTH-FACTOR; EVOKED-POTENTIALS; TRANSCALLOSAL INHIBITION; PROGNOSTIC VALUE; STROKE; DEPRESSION; CORTEX; REHABILITATION; EXCITABILITY;
D O I
10.1177/1545968319860483
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background. Although recent evidence has shown a new role of fluoxetine in motor rehabilitation, results are mixed. We conducted a randomized clinical trial to evaluate whether combining repetitive transcranial magnetic stimulation (rTMS) with fluoxetine increases upper limb motor function in stroke. Methods. Twenty-seven hemiparetic patients within 2 years of ischemic stroke were randomized into 3 groups: Combined (active rTMS + fluoxetine), Fluoxetine (sham rTMS + fluoxetine), or Placebo (sham rTMS + placebo fluoxetine). Participants received 18 sessions of 1-Hz rTMS in the unaffected primary motor cortex and 90 days of fluoxetine (20 mg/d). Motor function was assessed using Jebsen-Taylor Hand Function (JTHF) and Fugl-Meyer Assessment (FMA) scales. Corticospinal excitability was assessed with TMS. Results. After adjusting for time since stroke, there was significantly greater improvement in JTHF in the combined rTMS + fluoxetine group (mean improvement: -214.33 seconds) than in the placebo (-177.98 seconds, P = 0.005) and fluoxetine (-50.16 seconds, P < 0.001) groups. The fluoxetine group had less improvement than placebo on both scales (respectively, JTHF: -50.16 vs -117.98 seconds, P = 0.038; and FMA: 6.72 vs 15.55 points, P = 0.039), suggesting that fluoxetine possibly had detrimental effects. The unaffected hemisphere showed decreased intracortical inhibition in the combined and fluoxetine groups, and increased intracortical facilitation in the fluoxetine group. This facilitation was negatively correlated with motor function improvement (FMA, r(2) = -0.398, P = 0.0395). Conclusion. Combined fluoxetine and rTMS treatment leads to better motor function in stroke than fluoxetine alone and placebo. Moreover, fluoxetine leads to smaller improvements than placebo, and fluoxetine's effects on intracortical facilitation suggest a potential diffuse mechanism that may hinder beneficial plasticity on motor recovery.
引用
收藏
页码:643 / 655
页数:13
相关论文
共 50 条
  • [1] Fluoxetine for motor recovery after acute intracerebral hemorrhage (FMRICH): study protocol for a randomized, double-blind, placebo-controlled, multicenter trial
    Manuel Marquez-Romero, Juan
    Arauz, Antonio
    Luis Ruiz-Sandoval, Jose
    de la Cruz-Estrada, Erick
    Raquel Huerta-Franco, Maria
    Aguayo-Leytte, Geronimo
    Ruiz-Franco, Angelica
    Silos, Humberto
    TRIALS, 2013, 14
  • [2] Fluoxetine is not effective in the treatment of poststroke fatigue: A double-blind, placebo-controlled study
    Choi-Kwon, Smi
    Choi, Jimi
    Kwon, Sun U.
    Kang, Dong-Wha
    Kim, Jong S.
    CEREBROVASCULAR DISEASES, 2007, 23 (2-3) : 103 - 108
  • [3] Fluoxetine for motor recovery after acute intracerebral hemorrhage (FMRICH): study protocol for a randomized, double-blind, placebo-controlled, multicenter trial
    Juan Manuel Marquez-Romero
    Antonio Arauz
    José Luis Ruiz-Sandoval
    Erick de la Cruz-Estrada
    Maria Raquel Huerta-Franco
    Gerónimo Aguayo-Leytte
    Angélica Ruiz-Franco
    Humberto Silos
    Trials, 14
  • [4] Fluoxetine in early poststroke depression - A double-blind placebo-controlled study
    Wiart, L
    Petit, H
    Joseph, PA
    Mazaux, JM
    Barat, M
    STROKE, 2000, 31 (08) : 1829 - 1832
  • [6] A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF FLUOXETINE IN FIBROMYALGIA
    WOLFE, F
    CATHEY, MA
    HAWLEY, DJ
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1994, 23 (05) : 255 - 259
  • [7] The efficacy comparison of citalopram, fluoxetine, and placebo on motor recovery after ischemic stroke: a double-blind placebo-controlled randomized controlled trial
    Asadollahi, Marjan
    Ramezani, Mahtab
    Khanmoradi, Ziba
    Karimialavijeh, Ehsan
    CLINICAL REHABILITATION, 2018, 32 (08) : 1069 - 1075
  • [8] Fluoxetine treatment in poststroke depression, emotional incontinence, and anger proneness a double-blind, placebo-controlled study
    Smi, CK
    Han, SW
    Kwon, SU
    Kang, DW
    Choi, JM
    Kim, JS
    STROKE, 2006, 37 (01) : 156 - 161
  • [9] The Effect of Lithium in Post-Stroke Motor Recovery: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial
    Mohammadianinejad, Seyed Ehsan
    Majdinasab, Nastaran
    Sajedi, Seyed Aidin
    Abdollahi, Fahimeh
    Moqaddam, Mehdi Masoudi
    Sadr, Fatemeh
    CLINICAL NEUROPHARMACOLOGY, 2014, 37 (03) : 73 - 78
  • [10] Cerebrolysin and Recovery After Stroke (CARS) A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial
    Muresanu, Dafin F.
    Heiss, Wolf-Dieter
    Hoemberg, Volker
    Bajenaru, Ovidiu
    Popescu, Cristian Dinu
    Vester, Johannes C.
    Rahlfs, Volker W.
    Doppler, Edith
    Meier, Dieter
    Moessler, Herbert
    Guekht, Alla
    STROKE, 2016, 47 (01) : 151 - 159